Publicaciones en colaboración con investigadores/as de Uppsala University (7)

2018

  1. Effects of Teriparatide in Patients with Osteoporosis in Clinical Practice: 42-Month Results During and After Discontinuation of Treatment from the European Extended Forsteo® Observational Study (ExFOS)

    Calcified Tissue International, Vol. 103, Núm. 4, pp. 359-371

2016

  1. Fracture Rate, Quality of Life and Back Pain in Patients with Osteoporosis Treated with Teriparatide: 24-Month Results from the Extended Forsteo Observational Study (ExFOS)

    Calcified Tissue International, Vol. 99, Núm. 3, pp. 259-271

  2. Fracture rate, back pain and quality of life in patients with osteoporosis treated with teriparatide: Results of the European observational study ExFOS (Extended Forsteo® Observational Study)

    Revue du Rhumatisme (Edition Francaise), Vol. 83, pp. A188-A189

2012

  1. Effectiveness of teriparatide in postmenopausal women with osteoporosis and glucocorticoid use: 3-Year results from the EFOS study

    Journal of Rheumatology, Vol. 39, Núm. 3, pp. 600-609

  2. Effectiveness of teriparatide in women over 75 years of age with severe osteoporosis: 36-month results from the European Forsteo Observational Study (EFOS)

    Calcified Tissue International, Vol. 90, Núm. 5, pp. 373-383

  3. Effects of teriparatide in postmenopausal women with osteoporosis pre-treated with bisphosphonates: 36-month results from the European Forsteo Observational Study

    European Journal of Endocrinology, Vol. 166, Núm. 1, pp. 87-97

2010

  1. Cost effectiveness of teriparatide and PTH(1-84) in the treatment of postmenopausal osteoporosis

    Journal of Medical Economics, Vol. 13, Núm. 3, pp. 381-392